Charles Morris, MBBS

The chief executive and chief medical officers of Celyad Oncology discussed the company’s future research and plans.

The chief executive and chief medical officers of Celyad Oncology discussed their platform and positive data presented at EHA 2021.

The chief executive and chief medical officer of Celyad Oncology discussed the advantages of allogeneic CAR T therapies over autologous ones.